Clinical Trials in Georgia

Showing 5061-5080 of 14,426 trials

COMPLETED14 miles

Measuring Cardiovascular Performance and Blood Flow Using Common But Never Compared Methods.

NCT04553484

Measuring Cardiovascular Performance Using Common Methods in subjects.

D012039D001775

Semler Scientific657 participantsStarted Aug 2020

Macon, Georgia, United States • Lincoln, Nebraska, United States • Houston, Texas, United States +1 more locations

COMPLETEDPhase 165 miles

A Clinical Safety Study of AT-100 (rhSP-D) in Preterm Neonates at High Risk for Bronchopulmonary Dysplasia (BPD)

NCT04662151

The purpose of this study is to determine if an investigational drug, AT-100, can reduce the occurrence of Bronchopulmonary Dysplasia (BPD) in babies born premature, as compared to babies born premature who receive an air-sham alone.

Bronchopulmonary Dysplasia

Airway Therapeutics, Inc.37 participantsStarted Sep 2021

Tucson, Arizona, United States • Little Rock, Arkansas, United States • Los Angeles, California, United States +16 more locations

Measuring Cardiovascular Performance and Blood Flow Using Common But Never Compared Methods.

A Clinical Safety Study of AT-100 (rhSP-D) in Preterm Neonates at High Risk for Bronchopulmonary Dysplasia (BPD)

Find Trials by Condition in Georgia

Training in Exercise Activities and Motion for Growth (TEAM 4 Growth) RCT

Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation With Histone Deacetylase Inhibitors

Daratumumab-Based Therapy for the Treatment of Newly Diagnosed Multiple Myeloma With Kidney Failure

An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease

Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex

A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye Disease

Study Evaluating Single Dose Of ILV-095 In Psoriasis Subjects

A Study of Ixazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM)

Evaluate the Efficacy and Safety of TGR-1202 in Participants With Chronic Lymphocytic Leukemia Who Are Intolerant to Prior Therapy

QUILT-3.002: N-803 in Patients With Relapse/Refractory iNHL in Conjunction With Rituximab

A Study of Vibegron in Pediatric Participants 2 Years to Less Than (<) 18 Years of Age With NDO and on CIC

R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma

Efficacy of Human Placental Graft in Diabetic Foot Ulcers

Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung Cancer

A Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients With Untreated, Advanced Biliary Tract Cancer

The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia

AN0025 and Pembrolizumab Combination in Advanced Solid Tumors

A Study With TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc)